PBYI Next Earnings Date Notes

— Puma Biotechnology (NASDAQ: PBYI) is a biopharmaceutical company focused on the development & commercialization of innovative therapies to improve cancer care, with its lead product being NERLYNX® (neratinib), approved for the extended adjuvant treatment of early-stage HER2-positive breast cancer. For investors preparing for the next PBYI earnings call, it’s vital to track several core business metrics. Foremost are NERLYNX sales figures (both U.S. & ex-U.S.), which provide a direct gauge of commercial traction & market penetration. Pay close attention to trends in prescription growth, product revenue, & updates on payer coverage or reimbursement challenges. Pipeline development, specifically any clinical progress with new indications or complementary research, is also crucial for long-term prospects. Additionally, review gross margin, R&D expenses, & net income/loss to assess operational efficiency & sustainability. Corporate guidance on future growth strategies, partnership news, & regulatory milestones can also serve as leading indicators for potential shifts in Puma's trajectory. By keeping these metrics in focus, you’ll be better positioned to interpret Puma’s quarterly results and understand its outlook during the earnings call. The next projected earnings date for PBYI is 11/5/2026 after close (stay tuned for a confirmed earnings date once announced).

PBYI Next Earnings Date FAQ

On this page we presented the PBYI Next Earnings Date information for Puma Biotechnology along with recent past earnings dates. For Q2 of 2026, PBYI reported earnings of 0.190/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, PBYI reported earnings of -0.040/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, PBYI reported earnings of 0.290/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, PBYI reported earnings of 0.210/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, PBYI reported earnings of 0.150/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for PBYI is 11/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Puma Biotechnology. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Puma Biotechnology shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Puma Biotechnology next earnings dates as well as any other stock out there in our coverage universe, to see when the next PBYI earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up PBYI's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the PBYI next earnings date.